Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 9/20 | 0.59 |
| ▸ | CA9 | Q16790 | 9/20 | 0.59 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.59 |
| ▸ | MEN1 | O00255 | 3/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.55 |
| ▸ | PGR | P06401 | 3/20 | 0.54 |
| ▸ | CA2 | P00918 | 2/20 | 0.54 |
| ▸ | CA3 | P07451 | 2/20 | 0.54 |
| ▸ | CA4 | P22748 | 2/20 | 0.54 |
| ▸ | CA6 | P23280 | 2/20 | 0.54 |
| ▸ | CA5A | P35218 | 2/20 | 0.54 |
| ▸ | CA7 | P43166 | 2/20 | 0.54 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.54 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.52 |
| ▸ | HPGD | P15428 | 3/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30388813 | 1.00 | CA12 (0.59) | CA12CA9MCL1MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL23294784 | 0.98 | CA12 (0.58) | CA12CA9MCL1MEN1KMT2A | |
| SCHEMBL1099580 | 0.87 | CA9 (0.58) | CA12CA9MCL1MEN1KMT2A | |
| SCHEMBL15842681 | 0.84 | CA9 (0.59) | CA12CA9MCL1MEN1KMT2A | |
| SCHEMBL23294766 | 0.84 | CA12 (0.58) | CA12CA9MCL1MEN1KMT2A | |
| SCHEMBL19691118 | 0.84 | CA12 (0.58) | CA12CA9MCL1MEN1KMT2A | |
| SCHEMBL26054575 | 0.80 | CA9 (0.53) | CA12CA9MCL1MEN1KMT2A | |
| SCHEMBL15842312 | 0.80 | CA9 (0.53) | CA12CA9MCL1MEN1KMT2A | |
| SCHEMBL15842575 | 0.80 | CYP2A6 (0.57) | CA12CA9MCL1MEN1KMT2A | |
| SCHEMBL15842574 | 0.80 | PTPN1 (0.56) | CA12CA9MCL1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025033655-A1 | CHIRAL SUPRAMOLECULAR HIGH-ORDER STRUCTURE BASED ON CO-ASSEMBLY OF STAR-SHAPED BLOCK COPOLYMER AND CHIRAL ADDITIVE AND MANUFACTURING METHOD THEREOF | 이화여자대학교 산학협력단 | 2025-02-13 | — | — | WO | claimed |
| CN-119230977-A | Zinc ion battery electrolyte and preparation method and application thereof | 陕西延长石油售电有限公司 | 2024-12-31 | — | — | CN | claimed |
| CN-118558143-B | Method for preparing nanofiltration membrane based on pyrone acidic molecular additive regulation | 东华理工大学 | 2024-12-20 | — | — | CN | claimed |
| CN-118558143-A | Method for preparing nanofiltration membrane based on pyrone acidic molecular additive regulation | 东华理工大学 | 2024-08-30 | — | — | CN | claimed |
| EP-2295053-B1 | Novel 2H-chromen-2-one-3-carboxamides for medical uses | INST MATERIA MEDICA CAMS (CN) | 2016-10-19 | — | — | EP | claimed |
| US-8968711-B2 | Cosmetic or dermatological composition comprising a polymer bearing junction groups, and cosmetic treatment process | L'OREAL (FR) | 2015-03-03 | — | — | US | claimed |
| US-8338401-B2 | Coumarin-amide derivatives and its preparation, said drug composition and its use | INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2012-12-25 | — | — | US | claimed |
| EP-2295053-A1 | Novel 2H-chromen-2-one-3-carboxamides for medical uses | THE INSTITUTE OF MATERIA MEDICA OF CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2011-03-16 | — | — | EP | claimed |
| US-20100272660-A1 | COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT | L'OREAL (FR) | 2010-10-28 | — | — | US | claimed |
| US-20100239509-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS | L'OREAL (FR) | 2010-09-23 | — | — | US | claimed |
| CN-100488504-C | Coumarin amide derivative, its preparation method, its medicinal composition and application | INST MATERIA MEDICA CAMS (CN) | 2009-05-20 | — | — | CN | claimed |
| US-20060148834-A1 | Novel coumarin-amide derivatives and its preparation, said drug composition and its use | INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2006-07-06 | — | — | US | claimed |
| EP-1570846-A1 | THE NOVEL COUMARIN-AMIDE DERIVATIVES AND ITS PREPARATION, SAID DRUG COMPOSITION AND ITS USE | THE INSTITUTE OF MATERIA MEDICA OF CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2005-09-07 | — | — | EP | claimed |
| EP-3710428-B1 | MODULATORS OF THE INTEGRATED STRESS PATHWAY | CALICO LIFE SCIENCES LLC (US) | 2026-03-25 | — | — | EP | disclosed |
| EP-4683951-A2 | METHOD OF FUNCTIONALIZATION OF A BIOPOLYMER AND METHOD OF CROSS-LINKING THEREOF | Polbionica Spolka Akcyjna (PL) | 2026-01-28 | — | — | EP | disclosed |
| CN-119709024-A | Photo-curing adhesive, preparation method thereof, display screen and electronic equipment | 北京小米移动软件有限公司 | 2025-03-28 | — | — | CN | disclosed |
| EP-1988085-A1 | PROCESS FOR PRODUCTION OF 3-[5-[4-(CYCLOPENTYLOXY)-2-HYDROXYBENZOYL]-2-[(3-HYDROXY-1,2-BEZISOXAZOL-6-YL)METHOXY]PHENYL]PROPIONATE ESTER AND INTERMEDIATE FOR THE PROCESS | TOYAMA CHEMICAL CO., LTD. (JP) | 2008-11-05 | — | — | EP | disclosed |
| EP-1988085-A1 | PROCESS FOR PRODUCTION OF 3-[5-[4-(CYCLOPENTYLOXY)-2-HYDROXYBENZOYL]-2-[(3-HYDROXY-1,2-BEZISOXAZOL-6-YL)METHOXY]PHENYL]PROPIONATE ESTER AND INTERMEDIATE FOR THE PROCESS | TOYAMA CHEMICAL CO., LTD. (JP) | 2008-11-05 | — | — | EP | disclosed |
| US-20060148834-A1 | Novel coumarin-amide derivatives and its preparation, said drug composition and its use | INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2006-07-06 | — | — | US | disclosed |
| EP-1570846-A1 | THE NOVEL COUMARIN-AMIDE DERIVATIVES AND ITS PREPARATION, SAID DRUG COMPOSITION AND ITS USE | THE INSTITUTE OF MATERIA MEDICA OF CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2005-09-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060148834-A1 | Novel coumarin-amide derivatives and its preparation, said drug composition and its use | INSR, GLS, INSRR | CA12 3153/4885CA9 863/4885MCL1 779/4885 |
| US-20100239509-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS | CUTA, SUCLG1, KRT18 | CA12 15/4885CA9 120/4885MCL1 3462/4885 |
| US-20100272660-A1 | COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT | ACMSD, CUTA, PCCA | CA12 403/4885CA9 526/4885MCL1 3275/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.